Free Trial

SELLAS Life Sciences Group (SLS) Institutional Ownership

$1.19
-0.03 (-2.46%)
(As of 10/9/2024 ET)

Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)

Current
Institutional Ownership
Percentage
17.38%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$5.96M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$20.69K
Get SLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SLS Institutional Buying and Selling by Quarter

SELLAS Life Sciences Group Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024Renaissance Technologies LLC32,446$39K0.0%N/A0.056%
5/20/2024Virtu Financial LLC39,429$40K0.0%-34.2%0.068%
5/14/2024Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366%
4/26/2024Opus Capital Group LLC200,600$203K0.0%+48.6%0.356%
2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558%
1/31/2024Opus Capital Group LLC135,000$143K0.0%+291.3%0.421%
9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105%
5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367%
1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096%
11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501%
2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066%
2/11/2022Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642%
11/12/2021Jump Financial LLC14,627$134K0.0%N/A0.092%
11/12/2021Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630%
11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843%
8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533%
8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103%
8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103%
8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071%
8/16/2021State Street Corp37,468$416K0.0%N/A0.248%
8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560%
8/13/2021Northern Trust Corp24,605$273K0.0%+35.9%0.163%
8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672%
8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100%
8/12/2021Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135%
8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724%
8/11/2021Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135%
(Data available from 1/1/2016 forward)

SLS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SLS shares?

During the previous two years, the following institutional investors and hedge funds held shares of SELLAS Life Sciences Group shares: Anson Funds Management LP ($4.88M), Highbridge Capital Management LLC ($2.58M), Armistice Capital LLC ($869K), Empery Asset Management LP ($623K), Opus Capital Group LLC ($203K), Prosperity Financial Group Inc. ($47K), and Virtu Financial LLC ($40K).Learn more on SLS's institutional investors.

What percentage of SELLAS Life Sciences Group stock is owned by institutional investors?

17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings.

Which institutional investors have been buying SELLAS Life Sciences Group stock?

The following institutional investors have purchased SELLAS Life Sciences Group stock in the last 24 months: Anson Funds Management LP ($4.83M), Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Opus Capital Group LLC ($185.77K), Renaissance Technologies LLC ($32.45K), and Prosperity Financial Group Inc. ($29.80K).

How much institutional buying is happening at SELLAS Life Sciences Group?

Institutional investors have bought a total of 7,705,440 shares in the last 24 months. This purchase volume represents approximately $8.64M in transactions.

Which SELLAS Life Sciences Group major shareholders have been selling company stock?

The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($619.52K), and Virtu Financial LLC ($20.49K).

How much institutional selling is happening at SELLAS Life Sciences Group?

Institutional investors have sold a total of 640,003 shares in the last 24 months. This volume of shares sold represents approximately $1.27M in transactions.



This page (NASDAQ:SLS) was last updated on 10/9/2024 by MarketBeat.com Staff
From Our Partners